Robaczyńska, J.; Maj, M.; Kiljańczyk, A.; Pastuszek, B.; Reducha, E.; Nurkiewicz, A.; Kiljańczyk, M.
Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation. Cancers 2026, 18, 389.
https://doi.org/10.3390/cancers18030389
AMA Style
Robaczyńska J, Maj M, Kiljańczyk A, Pastuszek B, Reducha E, Nurkiewicz A, Kiljańczyk M.
Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation. Cancers. 2026; 18(3):389.
https://doi.org/10.3390/cancers18030389
Chicago/Turabian Style
Robaczyńska, Joanna, Maciej Maj, Adam Kiljańczyk, Bartosz Pastuszek, Emilia Reducha, Aleksandra Nurkiewicz, and Milena Kiljańczyk.
2026. "Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation" Cancers 18, no. 3: 389.
https://doi.org/10.3390/cancers18030389
APA Style
Robaczyńska, J., Maj, M., Kiljańczyk, A., Pastuszek, B., Reducha, E., Nurkiewicz, A., & Kiljańczyk, M.
(2026). Epigenetic and Liquid Biopsy Biomarkers in Prostate Cancer: Bridging Tumor Heterogeneity and Clinical Implementation. Cancers, 18(3), 389.
https://doi.org/10.3390/cancers18030389
